Skip to content ↓

Topic

Medicine

Download RSS feed: News Articles / In the Media / Audio

Displaying 1 - 15 of 687 news clips related to this topic.
Show:

Wisconsin Public Radio

In an article by Wisconsin Public Radio’s Hope Kirwan, Prof. Benjamin Vatter discusses hospitals being uncompensated for healthcare. Unpaid care may come from people who are “underinsured,” whose insurance plans still leave them responsible for a large portion of their care, says Vatter. If the “hospital doesn’t give them [patients] the option to negotiate a discount, the only option that is left for them is just not to pay it at all.”  

Popular Science

BIOSENTER, a soft, snake-like robot developed by MIT researchers, could autonomously snap photos, administer drugs, and take small biopsy samples within cramped and difficult to reach areas of the body such as the small intestine, writes Mack DeGeurin for Popular Science. “BIOSENTER has four inflatable chambers arranged along either side of its tubular body. These chambers inflate and deflate in alternating combinations, which is how it moves [forward] and bends to change directions,” explains DeGeurin. “Keeping with the snake theme, the robot’s exterior is fitted with a textured, scale-like coating that improves its traction.”  

Inside Precision Medicine

MIT researchers have developed BIOSENTER, a soft robot inspired by the movement of snakes, “designed to navigate the twists and turns of the small intestine [that] could perform real-time imaging, deliver drugs, and take biopsies deep within the digestive tract,” reports Inside Precision Medicine. “The robot’s tube-like body contains four inflatable chambers that can expand or contract in different combinations, allowing the robot to move forward and bend in different directions. A hollow central channel allows the robot to carry endoscopic tools, including a camera for imaging, a fluid sprayer for drug delivery, and clips for collecting tissue samples or removing small polyps.” 

Forbes

Forbes’ Lisa Chambers highlights MIT as one of the “12 top colleges reinventing education for the AI era.” “At Forbes’ No. 1-ranked college in the nation—and one of the world’s leading technology schools—AI is hardly confined to a single degree,” writes Chambers. “MIT’s undergraduate offerings range from machine learning, computer vision and natural language processing to robotics, deep-learning hardware and AI applications in biology and medicine.”  

Smithsonian Magazine

MIT researchers have invented a digestible, bioresorbable battery that can deliver drugs directly to the GI tract, reports Smithsonian Magazine’s Sara Hashemi. Prof. Giovanni Traverso and his colleagues “made two versions of the battery of different sizes and voltages,” writes Hashemi. “Exposing them to an acidic liquid similar to gastric fluid revealed they would function normally in the stomach for about three days.” 

The Economist

The Economist highlights MIT researchers’ new “paper-based battery whose components are safely absorbed by the body,” to help deliver drugs to the GI tract more effectively. “The new battery is a stack of magnesium, gel and chemically active paper—all coated in wax to protect it from the harsh environment of the gut. It is also compact, taking up only about a quarter of the space inside a standard gelatine capsule, leaving plenty of room for the device it is to power, as well as other useful payloads, such as a drug.”  

The Financial Times

MIT researchers have developed an ingestible battery that could be used to monitor drug delivery and avoid the need for surgery; a “milestone towards potential human use for health monitoring and treatments,” writes Michael Peel for the Financial Times. Improving the effectiveness of therapies “moves the technology beyond a materials demonstration toward an integrated biomedical system,” says Prof. Giovanni Traverso, senior author of the study.  

Financial Times

The Financial Times’ Anjana Ahuja highlights Prof. Sangeeta Bhatia and Senior Postdoctoral Associate Vardhman Kumar’s work developing injectable “mini livers,” tissue grafts that could “take on some of the life-saving functions of liver cells: helping with blood clotting, detoxifying the bloodstream and breaking down medicines. The injectable grafts, they suggest, could also be used as a bridging treatment while patients wait for a transplant, with booster injections able to dial up the dose,” writes Ahuja.  

The New York Times

Prof. Jonathan Weissman speaks with The New York Times’ Emily Baumgaertner Nunn about epigenome editing, including a single injection that would silence a gene in the liver that destroys receptors responsible for clearing LDL cholesterol. “This is sort of the ultimate one-and-done treatment,” says Weissman. “I don’t think we know enough to be able to do it at the moment, but it is not so far off from what’s imaginable.”  

STAT

In a STAT opinion piece, Arya Rao, a candidate in the Harvard/MIT MD-PhD program, and Marc Succi write about how AI impacts clinical reasoning. “[C]linical reasoning and model reasoning are not the same thing,” Rao and Succi explain. “AI not only lacks this hidden framework and data repository for learning, but it arrives at conclusions using a fundamentally different method.” 

Forbes

Writing for Forbes, Joseph Coughlin, director of the MIT AgeLab, emphasizes the importance of longevity planning for retirement. “For decades, preparedness meant saving enough, investing wisely, paying down debt, and entering retirement financially secure,” writes Coughlin. “Those remain essential. But longer lives are changing what it means to be prepared. Retirement planning now requires longevity planning — preparing for the long game of more years of life and all the things that life exposes us to.” 

 

Ohio 10 WBNS

Jay Fox of the Ohio News Network joins Ohio 10 WBNS to discuss his conversation with President Sally Kornbluth about how life-changing scientific innovations in university research labs have helped build our nation’s technological prowess and ensured our strength and stability, explaining how federal research cuts threaten future medical and technological advances. “What’s at risk are the kind of cures and technological advances that we’ll enjoy as we age, as our children get older and their children’s children get older. It’s really the future that is being mortgaged at this point,” said Kornbluth during her discussion with Fox. 

Popular Science

Popular Science reporter Laura Baisas showcases an ingestible, berry-size thermometer developed by MIT researchers that could offer continuous monitoring for sick patients. The sensor “could make it easier to determine whether a patient is sick and if they’re at risk of developing a dangerously high fever. It can also help for people tracking their fertility or those under anesthesia," writes Baisas. "The team is now working on combining the temperature sensor with different sensors that could measure other vital signs such as heart rate." 

Inside Precision Medicine

Inside Precision Medicine spotlights Prof. Giovanni Traverso and his team’s work developing an oral drug formulation containing hydrogel that allows for the delivery of small molecules and antibodies via the esophageal mucosal lining. “We were interested in delivering anti-TNFs as a model drug, but also to help people who suffer from conditions like Crohn’s disease to have options that could be delivered to the site,” says Traverso. “If we have the possibility of site-directed delivery, we may be able to mitigate systemic side effects from these immunosuppressing agents.”

Forbes

In a Forbes article, contributor Wes Kilgore cites a study by MIT economists that reveals how timely hospice use can create healthcare savings in the U.S. “When families avoid hospice because of fear or legal confusion, patients return to emergency rooms, see specialists, undergo procedures, and drive-up Medicare costs,” writes Kilgore.